CSIR-HRDC hosts intensive workshop on AI-driven drug discovery for scientists
Three-day programme equips CSIR researchers with advanced AI tools, molecular docking insights, and biomolecular simulation expertise
Three-day programme equips CSIR researchers with advanced AI tools, molecular docking insights, and biomolecular simulation expertise
The enhanced allocation will be directed toward expanding healthcare infrastructure, increasing patient capacity, and widening acces
A major highlight of the event was the launch of several publications and digital initiatives, including a certification course on the Ayush Grid portal
Minister highlights RDI fund, private participation in space and nuclear sectors, and calls for faster reforms to improve ease of research in India
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga
For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms
Landmark procedure restores 32-year-old CKD patient’s health, highlighting how public insurance is widening access to advanced renal care
Drugmaker taps 1 million retail touchpoints, quick commerce and modern trade to expand ingredient-led skincare franchise
Both ordinary resolutions sail through with over 99.6% votes in favour, strengthening leadership continuity at the drugmaker
Subscribe To Our Newsletter & Stay Updated